Kern C et al., 2026: Pharmacometric comparison in healthy Kenyan adults of a single 400 mcg/kg dose against 300 mcg/kg on three consecutive days, modelling how long concentrations stay above the mosquito-lethal threshold. The authors present it as informing dosing for mass drug administration trials.
Healthy adults in Kenya received either ivermectin once (1 × 400 µg/kg) or on 3 consecutive days (3 × 300 µg/kg).
Kern C et al., 2026: Pharmacometric comparison in healthy Kenyan adults of a single 400 mcg/kg dose against 300 mcg/kg on three consecutive days, modelling how long concentrations stay above the mosquito-lethal threshold. The authors present it as informing dosing for mass drug administration trials. C2 dosing regimens. Study type: pharmacokinetic trial with pharmacometric modelling; healthy adults in Kenya; N not stated in the abstract captured; Kenya. Doses: 1 x 400 mcg/kg single dose vs 3 x 300 mcg/kg on consecutive days, oral; plasma and dried blood spot sampling. Comparator: the two regimens against each other. Funder: not stated in the PubMed record. Declared conflicts: 'The authors have no competing interests to declare.'
